Pharmaceuticals
Healthcare
Symbiotec eyes IPO to give exit to PE investors; can it command a high valuation?
Bulk drug maker Symbiotec Pharmalab is planning to explore the possibility of floating an initial public offering in the......
Healthcare
India SME Investments makes second bet from latest fund
India SME Investments, a private equity firm that is currently in the process of raising its second fund, is set ......
Healthcare
Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask
Private equity giant KKR is considering a new multi-billion dollar plan to monetise its four-year-old bet on JB ......
Healthcare
What are Carlyle-backed Sequent Scientific's plans after recent merger announcement?
Private equity firm Carlyle-controlled SeQuent Scientific Ltd. aims to establish a larger platform focussed on pure-play......
Healthcare
Rivendell signing off from a legacy India PE bet with a haircut
Private equity firm Rivendell PE, which was co-founded by Parag Saxena and Rajat Gupta, former McKinsey chief who faced ......
Healthcare
Zydus Life acquires Sterling Biotech's API formulation business
Listed pharma player Zydus Lifesciences, erstwhile Cadila Healthcare, has announced the acquisition of Sterling Biotech......
Healthcare
Exclusive: Micro Labs set to acquire Nigerian generics company
Bengaluru-based pharmaceuticals firm Micro Labs Ltd is close to acquiring a Nigerian pharmaceutical company, in what ......
Healthcare
Searchlight: Hetero Health rebounds after post-COVID crash on manufacturing boost
Hetero Healthcare Ltd, which is a part of one of the major pharmaceutical groups in India Hetero group, witnessed a ......
Healthcare
Searchlight: Allchem Lifescience bets big on capacity expansion after record revenue
Active pharmaceutical ingredient (API) and pharma intermediates maker Allchem Lifescience recorded a rise in its topline......
Healthcare
True North-backed Integrace set to add new names on cap table
Mumbai-based pharmaceutical player Integrace Pvt. Ltd, backed by Singapore’s Temasek and homegrown private equity firm......